Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

 

  • A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors.
  • An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence.

For more information, download the pdf below or contact us : contact@ypso-facto.com 

 

We use cookies to enhance the user experience and analyze website traffic. Learn how we use cookies and how you can control them by clicking on "Privacy Preferences".

Privacy Preferences

When you visit a website, it may store or retrieve information on your browser, mostly in the form of cookies. Because we respect your right to privacy, you can choose not to allow some types of services. However, not allowing these services may impact your experience.